Greyrigge Associates partner with SciPot Consultancy

GreyRigge setup a formal collaboration with SciPot Consultancy.

Melody Janssen, Ph.D., SciPot Consultancy’s Director and Principal Consultant works on small molecules, peptides, recombinant human proteins, antibodies, vaccines (human and veterinary), ADCs, ATMPs/GCTs to drug delivery systems and biosimilars.

Melody is an authority in her field and in high demand across the Bio Industry.  While Melody has long been an expert Pre-clinical & (bio) analytical Consultant working with GreyRigge, this new partnership means that SciPot Consultancy will be introducing GreyRigge's extensive portfolio of services to new clients.

Building trust in our industry is imperative. So when you have a supplier that you trust and respect, it is often a great idea to see what else they can offer. By working in partnership with Melody, we plan to extend our footprint into many of our new and existing clients…helping them bring products to market faster.

By far, not the only measure of excellence, over 80% of GreyRigge Associates boast MSc and PhD's, and Melody is no exception.

She has always been fascinated by the versatile nature of viruses and how some of them manage to escape the immune system so effectively.

Naturally, when it was time to choose a study, it had to be infectious diseases.

She chose to study “human biology” at the Philipps University of Marburg, majoring in infectious diseases. Her master thesis was based on work on the Rift Valley Fever Virus and completed at Health Canada under the supervision of Dr. Heinz Feldmann.

During her PhD, Melody wanted to continue working in virology in a Biosafety level 4 lab, but life can take unpredicted turns and her path instead led the University of Utrecht and the Drug Delivery group, where, under the supervision of the renowned Prof. Huub Schellekens and Prof. Wim Jiskoot, she finished her PhD investigating the effects of protein aggregates on immunogenicity. During that time, she was already heavily involved in the immunogenicity community and also worked with MSD, Roche and Merck Serono.

For more than a decade she has been a member of the European Immunogenicity Platform, EIP, where she is  part of a European network of immunogenicity experts and beyond.

To learn more about Melody, her credentials, skills and experiences, click through to her GreyRigge profile. https://www.greyrigge.com/team/melody-janssen